Rhaeos
PrivateLast Round
Grant
Oct 9, 2023
Total Funding Raised
$15.84M
Company Overview
Rhaeos is a medical device company developing FlowSense, a noninvasive wearable sensor designed to monitor bodily fluid flow, initially for hydrocephalus patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhaeos Comparables
Compare Rhaeos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroDx Development | 91% | |
| Madison Scientific | 83% | |
| Kitea Health | 81% |
Rhaeos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 9, 2023 | ||||
| Series A | Feb 16, 2023 | ||||
| Seed | Dec 23, 2021 | ||||
| Accelerator | Sep 27, 2021 | ||||
| Grant | Mar 1, 2021 | ||||
Grant | Oct 6, 2020 |
Key People
Founding team and executive leadership
Rhaeos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| NIH RADx | Grant, Accelerator |
| Creative Ventures | Series A, Seed |
| Lateral Capital | Series A, Seed |
| A1 Health Ventures | Grant |
| National Institute of Neurological Disorders and Stroke | Grant, Accelerator |
| Band of Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 36% MoM, reaching 1.8K.
- Oct 9, 2023
$1.5M grant from A1 Health Ventures and NIH
Rhaeos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rhaeos's valuation, stock price, and market status.
Is Rhaeos a public or private company?
Rhaeos is a private company.
What is the current stock price of Rhaeos?
Rhaeos is a private company with no public stock price. No recent secondary market data is available.
How much is Rhaeos worth (valuation)?
Valuation information for Rhaeos is not publicly available.
Can I buy Rhaeos stock?
Rhaeos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rhaeos's last funding round?
Rhaeos's most recent funding round was Grant on October 9, 2023.
Who are the main investors in Rhaeos?
Key investors in Rhaeos include Steele Foundation for Hope.
Will Rhaeos IPO soon?
No public IPO plans have been announced for Rhaeos.
How can I track Rhaeos secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rhaeos's secondary market activity and sign up for updates.